India Sets Sights on Malaria Elimination by 2030
India’s success story is a testament of active grassroots participation, and targeted, evidence-driven interventions. The National Framework for Malaria Elimination (2016–2030) and the recently launched National Strategic Plan (2023–2027) have provided a robust roadmap, aligning with global strategies while tailoring solutions to address specific local needs.
India Launches National Zero Measles-Rubella Elimination Campaign 2025-26
Measles and Rubella, highly contagious viral diseases, can lead to severe complications and even death. India has set a target to eliminate these diseases by 2026, leveraging the Universal Immunization Programme (UIP), which provides two free doses of the MR vaccine to eligible children at 9-12 months and 16-24 months.
Kerala State PCB Relaxes Authorization Fee for Laboratories & Clinics
All new applications for authorization for non-bedded clinics and laboratories will now be subject to the standard perpetual validity fee structure without any deduction based on fees paid under the earlier time-bound system.
Central Government Restricts Use of Common Cold Drug Combination in Children Under Four
The Central Government has now mandated that all manufacturers of fixed-dose combinations of Chlorpheniramine Maleate and Phenylephrine Hydrochloride must clearly and prominently mention the warning “fixed dose combination shall not be used in children below four years of age” on the label, package insert, and any promotional literature associated with the drug.
CDSCO Revises Drug Alert List For November 2024 & January 2025
The Central Drugs Standard Control Organisation (CDSCO) has issued drug alerts for specific batches of Tofacitinib Tablets IP 5 mg (marketed as TOFAJAK TABLETS) and TELMA AM, declaring them as potentially spurious following investigations into their quality. Consumers and healthcare providers are advised to stay informed about such alerts issued by regulatory authorities to ensure the safety and efficacy of the medications they use or dispense.
CDSCO Publishes Not Of Standard Quality And Spurious Alert For March 2025
The NSQ drug list specifies a total of 61 drugs that were detected to be deficient by State Lab Drugs Control Laboratories. The NSQ drug list for central CDSCO laboratories specifies a total of 70 drugs that were detected to be deficient. Additionally, CDSCO has also identified 1 drug to be spurious.
Telangana Issues New Draft Law for Gig Workers Welfare & Rights
Telangana introduces draft bill to secure rights, welfare, and benefits for gig and platform workers, including mandatory registration and social security.
India Achieves Milestone in Preventive Healthcare with Indigenous HPV Test Kits for Cervical Cancer Screening
India has marked another significant stride in preventive healthcare with the development of indigenously manufactured HPV test kits for cervical cancer screening. This achievement, spearheaded by the Department of Biotechnology (DBT) under the Ministry of Science & Technology, was lauded by Union Minister of State (Independent Charge) for Science and Technology during a joint review meeting held on April 23, 2025.
Union Health Minister Leads “Liver Health Pledge” on World Liver Day
In commemoration of World Liver Day 2025, Union Minister of Health and Family Welfare spearheaded a “Liver Health Pledge Ceremony” at a health camp organized by the Ministry at Nirman Bhawan. The event underscored this year’s global theme: “Food is Medicine,” highlighting the vital link between nutrition and liver well-being.
AERB Discontinues Authorization for State Level Radiation Safety Directorates
The Atomic Energy Regulatory Board (AERB) has announced the discontinuation of its practice of authorizing State Level Directorates of Radiation Safety (DRS), citing evolving regulatory strategies and the lapse of existing Memorandums of Understanding (MOUs). The decision reflects the AERB’s ongoing efforts to strengthen its regulatory framework for medical diagnostic X-ray facilities.
